Background:
Point-of-care tests (POCTs) for influenza are diagnostically superior to clinical diagnosis, but their impact on patient outcomes is unclear.
Methods:
A systematic review of influenza POCTs versus usual care in ambulatory care settings. Studies were identified by searching six databases and assessed using the Cochrane risk of bias tool. Estimates of risk ratios (RR), standardised mean differences, 95% confidence intervals and I2 were obtained by random effects meta-analyses. We explored heterogeneity with sensitivity analyses and meta-regression.
Results:
12,928 citations were screened. Seven randomised studies (n=4,324) and six non-randomised studies (n=4,774) were included. Most evidence came from paediatric emergency departments. Risk of bias was moderate in randomised studies and higher in non-randomised studies. In randomised trials, POCTs had no effect on admissions (RR 0.93, 95% CI 0.61-1.42, I2=34%), returning for care (RR 1.00 95% CI=0.77-1.29, I2=7%), or antibiotic prescribing (RR 0.97, 95% CI 0.82-1.15, I2=70%), but increased prescribing of antivirals (RR 2.65, 95% CI 1.95-3.60; I2=0%). Further testing was reduced for full blood counts (FBC) (RR 0.80, 95% CI 0.69-0.92 I2=0%), blood cultures (RR 0.82, 95% CI 0.68-0.99; I2=0%) and chest radiography (RR 0.81, 95% CI 0.68-0.96; I2=32%), but not urinalysis (RR 0.91, 95% CI 0.78-1.07; I2=20%). Time in the emergency department was not changed. Fewer non-randomised studies reported these outcomes, with some findings reversed or attenuated (fewer antibiotic prescriptions and less urinalysis in tested patients).
Conclusions:
Point-of-care testing for influenza influences prescribing and testing decisions, particularly for children in emergency departments. Observational evidence shows challenges for real-world implementation.